Pharegis LLC / ООО "Фареджис"

Feed - News and features

• Medtronic drops $738m takeover of wearable insulin pump firm
  Medtech giant Medtronic has decided...
• Biden may order compulsory licensing in drug pricing move
  The White House said today that it may...
• Ipsen/Genfit eye June FDA verdict for liver drug elafibranor
  The FDA has kicked off a priority...
• Trial finds Lilly’s Olumiant could treat type 1 diabetes
  Treatment with Eli Lilly’s JAK...

PharmaTimes: News RSS

• Lung cancer screening recommended in Scotland, Wales and Northern Ireland
• Study reveals reducing oxygen levels for children in ICUs will save lives
• Secretary of state sets out priorities for UK health and social care systems
• Study reveals motor neuron region is affected in ALS
• KCL molecular communication system to revolutionise drug delivery

• Relaunched EMA website now live
• EU medicines agencies reflect on lessons learned from COVID-19
• Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023
• Consumption of antimicrobials in animals reaches lowest level ever in Europe

• Primary Graft Dysfunction, Pronation, Bilateral Lung Transplants
• Influence of Prenatal and Early Childhood Home-Visiting by Nurses on Development of Chronic Disease
• Phase III Clinical Trial Evaluating the Efficacy and Safety of 5-aminolevulinic Acid (5-ALA）
• Protein Fermentation Unraveled (PROFUN) - Exploring the Relationship Between Digestibility and Metabolite Production